- Home
- LUCD vs VTEX Comparison
LUCD vs VTEX Comparison
Compare LUCD & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- VTEX
- Stock Information
- Founded
- LUCD 2018
- VTEX 1999
- Country
- LUCD United States
- VTEX Cayman Islands
- Employees
- LUCD 70
- VTEX N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VTEX Computer Software: Prepackaged Software
- Sector
- LUCD Health Care
- VTEX Technology
- Exchange
- LUCD Nasdaq
- VTEX Nasdaq
- Market Cap
- LUCD 135.6M
- VTEX N/A
- IPO Year
- LUCD 2021
- VTEX 2021
- Fundamental
- Price
- LUCD $1.16
- VTEX $6.03
- Analyst Decision
- LUCD Strong Buy
- VTEX Strong Buy
- Analyst Count
- LUCD 4
- VTEX 2
- Target Price
- LUCD $3.88
- VTEX $8.75
- AVG Volume (30 Days)
- LUCD 1.3M
- VTEX 741.2K
- Earning Date
- LUCD 05-14-2025
- VTEX 05-06-2025
- Dividend Yield
- LUCD N/A
- VTEX N/A
- EPS Growth
- LUCD N/A
- VTEX N/A
- EPS
- LUCD N/A
- VTEX 0.07
- Revenue
- LUCD $4,346,000.00
- VTEX $228,237,000.00
- Revenue This Year
- LUCD $107.75
- VTEX $13.67
- Revenue Next Year
- LUCD $231.37
- VTEX $16.81
- P/E Ratio
- LUCD N/A
- VTEX $85.98
- Revenue Growth
- LUCD 79.00
- VTEX 7.72
- 52 Week Low
- LUCD $0.63
- VTEX $4.20
- 52 Week High
- LUCD $1.80
- VTEX $8.24
- Technical
- Relative Strength Index (RSI)
- LUCD 41.93
- VTEX 70.73
- Support Level
- LUCD $1.19
- VTEX $5.24
- Resistance Level
- LUCD $1.24
- VTEX $6.15
- Average True Range (ATR)
- LUCD 0.07
- VTEX 0.21
- MACD
- LUCD -0.00
- VTEX 0.09
- Stochastic Oscillator
- LUCD 15.79
- VTEX 90.34
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.